An Open-label, Multiple-dose, Two-arm, One-sequence, Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of amlodipine10mg and candesartan32mg in Healthy Male Volunteers

Trial Profile

An Open-label, Multiple-dose, Two-arm, One-sequence, Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of amlodipine10mg and candesartan32mg in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Aug 2015

At a glance

  • Drugs Amlodipine; Candesartan cilexetil
  • Indications Hypertension
  • Focus Pharmacokinetics
  • Sponsors HanAll Biopharma
  • Most Recent Events

    • 24 Feb 2014 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 15 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top